Table 1. Patients baseline characteristics (N=67).
| Characteristics | Number subject, N [%] |
|---|---|
| Age (years) | |
| Median [range] | 60 [30–87] |
| Sex | |
| Female | 33 [49] |
| Male | 34 [51] |
| Ethnicity | |
| African American | 15 [22] |
| Hispanic | 1 [2] |
| White | 51 [76] |
| Diagnosis | |
| Anal SCC | 5 [7] |
| Cholangiocarcinoma | 1 [2] |
| Colon adenocarcinoma | 33 [49] |
| Esophageal adenocarcinoma | 1 [2] |
| Gastric adenocarcinoma | 4 [6] |
| Neuroendocrine tumor (SB) | 1 [2] |
| Pancreatic adenocarcinoma | 3 [4] |
| Rectal adenocarcinoma | 19 [28] |
| Chemotherapy regimen | |
| Fluorouracil-based | 34 [51] |
| Capecitabine-based | 33 [49] |
SCC, squamous cell carcinoma; SB, small bowel.